These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 33346032)

  • 21. Mangiferin: An effective therapeutic agent against several disorders (Review).
    Du S; Liu H; Lei T; Xie X; Wang H; He X; Tong R; Wang Y
    Mol Med Rep; 2018 Dec; 18(6):4775-4786. PubMed ID: 30280187
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mangiferin: A xanthonoid with multipotent anti-inflammatory potential.
    Saha S; Sadhukhan P; Sil PC
    Biofactors; 2016 Sep; 42(5):459-474. PubMed ID: 27219011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protective effects of mangiferin on cerebral ischemia-reperfusion injury and its mechanisms.
    Yang Z; Weian C; Susu H; Hanmin W
    Eur J Pharmacol; 2016 Jan; 771():145-51. PubMed ID: 26656757
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autophagy as an essential cellular antioxidant pathway in neurodegenerative disease.
    Giordano S; Darley-Usmar V; Zhang J
    Redox Biol; 2014; 2():82-90. PubMed ID: 24494187
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Neuropharmacological effect of Mangiferin on brain cholinesterase and brain biogenic amines in the management of Alzheimer's disease.
    Biradar SM; Joshi H; Chheda TK
    Eur J Pharmacol; 2012 May; 683(1-3):140-7. PubMed ID: 22426032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The potential role of mangiferin in cancer treatment through its immunomodulatory, anti-angiogenic, apoptopic, and gene regulatory effects.
    Núñez Selles AJ; Daglia M; Rastrelli L
    Biofactors; 2016 Sep; 42(5):475-491. PubMed ID: 27219221
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mangiferin protect myocardial insults through modulation of MAPK/TGF-β pathways.
    Suchal K; Malik S; Gamad N; Malhotra RK; Goyal SN; Ojha S; Kumari S; Bhatia J; Arya DS
    Eur J Pharmacol; 2016 Apr; 776():34-43. PubMed ID: 26921754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mangiferin: a natural miracle bioactive compound against lifestyle related disorders.
    Imran M; Arshad MS; Butt MS; Kwon JH; Arshad MU; Sultan MT
    Lipids Health Dis; 2017 May; 16(1):84. PubMed ID: 28464819
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New therapeutic strategy for Parkinson's and Alzheimer's disease.
    Esposito E; Cuzzocrea S
    Curr Med Chem; 2010; 17(25):2764-74. PubMed ID: 20586718
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanistic new insights of flavonols on neurodegenerative diseases.
    Tahir MS; Almezgagi M; Zhang Y; Bashir A; Abdullah HM; Gamah M; Wang X; Zhu Q; Shen X; Ma Q; Ali M; Solangi ZA; Malik WS; Zhang W
    Biomed Pharmacother; 2021 May; 137():111253. PubMed ID: 33545661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Protective effect of alpha mangostin on rotenone induced toxicity in rat model of Parkinson's disease.
    Parkhe A; Parekh P; Nalla LV; Sharma N; Sharma M; Gadepalli A; Kate A; Khairnar A
    Neurosci Lett; 2020 Jan; 716():134652. PubMed ID: 31778768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic and cosmetic applications of mangiferin: a patent review.
    Telang M; Dhulap S; Mandhare A; Hirwani R
    Expert Opin Ther Pat; 2013 Dec; 23(12):1561-80. PubMed ID: 24066838
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mangiferin and organ fibrosis: A mini review.
    Zhang L; Huang C; Fan S
    Biofactors; 2021 Jan; 47(1):59-68. PubMed ID: 33217771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mangiferin: the miraculous xanthone with diverse pharmacological properties.
    Dutta T; Das T; Gopalakrishnan AV; Saha SC; Ghorai M; Nandy S; Kumar M; Radha ; Ghosh A; Mukerjee N; Dey A
    Naunyn Schmiedebergs Arch Pharmacol; 2023 May; 396(5):851-863. PubMed ID: 36656353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mangiferin, a natural xanthone, protects murine liver in Pb(II) induced hepatic damage and cell death via MAP kinase, NF-κB and mitochondria dependent pathways.
    Pal PB; Sinha K; Sil PC
    PLoS One; 2013; 8(2):e56894. PubMed ID: 23451106
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mangiferin: a promising anticancer bioactive.
    Khurana RK; Kaur R; Lohan S; Singh KK; Singh B
    Pharm Pat Anal; 2016 May; 5(3):169-81. PubMed ID: 27088726
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A pervasive scientific overview on mangiferin in the prevention and treatment of various diseases with preclinical and clinical updates.
    Mittal S; Iqubal MK; Iqbal B; Gupta MM; Ali J; Baboota S
    J Complement Integr Med; 2020 May; 18(1):9-21. PubMed ID: 32427121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nrf2/HO-1 mediates the neuroprotective effect of mangiferin on early brain injury after subarachnoid hemorrhage by attenuating mitochondria-related apoptosis and neuroinflammation.
    Wang Z; Guo S; Wang J; Shen Y; Zhang J; Wu Q
    Sci Rep; 2017 Sep; 7(1):11883. PubMed ID: 28928429
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mangiferin attenuates lipopolysaccharide-induced neuronal injuries in primary cultured hippocampal neurons.
    Tan H; Liang D; Lu N; Zhang J; Zhang S; Tan G
    Aging (Albany NY); 2024 May; 16(10):8645-8656. PubMed ID: 38752883
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mangiferin: A review of sources and interventions for biological activities.
    Jyotshna ; Khare P; Shanker K
    Biofactors; 2016 Sep; 42(5):504-514. PubMed ID: 27658353
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.